WHO ICTRP trial
Maternal pertussis immunization in Finland, 4 years (MIFI-4Y)
CTIS2024-510787-23-00 · EU Clinical Trials Information System · Recruiting
Key facts
| Trial ID | CTIS2024-510787-23-00 |
|---|---|
| Public title | Maternal pertussis immunization in Finland, 4 years (MIFI-4Y) |
| Scientific title | Maternal pertussis immunization in Finland, 4 years (MIFI-4Y) - MIFI-4Y |
| Primary sponsor | Varsinais-Suomen hyvinvointialue |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): No Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): Yes |
| Countries | Finland |
| Conditions | Pertussis MedDRA version: 21.1Level: PTClassification code: 10069577Term: Pertussis immunisation Class: 100000004865;Therapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01];Therapeutic area: Diseases [C] - Respiratory Tract… |
| Interventions | Product Name: Tetravac, injektioneste, suspensio Adsorboitu kurkkumätä-, jäykkäkouristus-, hinkuyskä- (soluton, komponentti) ja polio (inaktivoitu) - rokote, Product Code:PRD4559753, Pharmaceutical Form: SUSPENSION FOR INJECTION, Other… |
| Registration date | Nov 1, 2024 |
| Target size | 138 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: